Ca2+-CaM activation of AMP deaminase contributes to adenine nucleotide dysregulation and phosphatidylserine externalization in human sickle erythrocytes.
about
Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease.Adenosine monophosphate deaminase 3 activation shortens erythrocyte half-life and provides malaria resistance in mice.Pathophisiology of sickle cell disease and new drugs for the treatment.Hypoxia modulates the purine salvage pathway and decreases red blood cell and supernatant levels of hypoxanthine during refrigerated storage.
P2860
Ca2+-CaM activation of AMP deaminase contributes to adenine nucleotide dysregulation and phosphatidylserine externalization in human sickle erythrocytes.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Ca2+-CaM activation of AMP dea ...... in human sickle erythrocytes.
@en
Ca2+-CaM activation of AMP dea ...... in human sickle erythrocytes.
@nl
type
label
Ca2+-CaM activation of AMP dea ...... in human sickle erythrocytes.
@en
Ca2+-CaM activation of AMP dea ...... in human sickle erythrocytes.
@nl
prefLabel
Ca2+-CaM activation of AMP dea ...... in human sickle erythrocytes.
@en
Ca2+-CaM activation of AMP dea ...... in human sickle erythrocytes.
@nl
P2093
P2860
P1476
Ca2+-CaM activation of AMP dea ...... in human sickle erythrocytes.
@en
P2093
Cheryl A Hillery
Nancy J Wandersee
Richard L Sabina
P2860
P304
P356
10.1111/J.1365-2141.2008.07473.X
P407
P577
2008-11-19T00:00:00Z